(Q36921250)

17 August 2017

Is mycophenolate mofetil really necessary in renal transplantation? A review of the MYSS follow-up study (English)

1 reference

17 August 2017

Daniel C Brennan

1

1 reference

PubMed ID

17724486

17 August 2017

Matthew J Koch

series ordinal

2

1 reference

17 August 2017

28 August 2007

1 reference

Nature Clinical Practice Nephrology

17 August 2017

1 reference

17 August 2017

3

1 reference

17 August 2017

11

1 reference

17 August 2017

602-603

1 reference

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

17 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0597

7 January 2021

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0597

7 January 2021

Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0597

7 January 2021

Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0597

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0597

1 reference

17 August 2017

1 reference

PubMed ID

17724486